Identifying barriers and policy priorities for rare disease research in underrepresented European countries
European Journal of Public Health · 10.06.2026 · 36 (4)
DOI: 10.1093/eurpub/ckag103 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Public Health, online erschienen am 13.06.2026. Verfasst von Baiba Lace und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Riga East University hospital, University of Latvia, Riga, Latvia. Hauptthemen laut MEDLINE: Rare Diseases, Biomedical Research, Health Policy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union under the Horizon Europe programme.
Abstract (Originalsprache)
The European Joint Programme on Rare Diseases successfully advanced rare disease research and also revealed challenges for underrepresented countries, those less frequently holding or leading grants. This study aimed to survey Rare Disease researchers in these countries, identify barriers to participation in research, and propose solutions. A modified Delphi approach without formal consensus thresholds of 186 respondents highlighted fragmented or outdated policies and heterogeneous funding. Nearly all participants prioritized the need for EU-wide policies defining minimum quality standards for Rare Disease care. Key priorities include access to genetic testing and essential services to support uniform care and shared research capacity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Genetics, Riga East University hospital, University of Latvia, Riga, Latvia.
- Centre of Pathology, Riga East University hospital, Latvian Biomedical Research and Study Centre, Riga, Latvia.
- EURORDIS, Paris, France.
- INSERM, Paris, France.
- Georgian Foundation for Genetic and Rare Diseases, Tbilisi, Georgia.
- Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
ORCID-Profile: Baiba Lace
Förderung
- European Union under the Horizon Europe programme
Zitieren
APA
Lace, B., Inashkina, I., Dan, D., Weinman, A., Adam, P., Kvlividze, O., Tumiene, B., Isidro, A., Pereira, C. A., Teixeira, G., Crowley, R. K., & ERDERA UC Stakeholder Panel (2026). Identifying barriers and policy priorities for rare disease research in underrepresented European countries. European Journal of Public Health, 36(4). https://doi.org/10.1093/eurpub/ckag103
Vancouver
Lace B, Inashkina I, Dan D, Weinman A, Adam P, Kvlividze O, et al. Identifying barriers and policy priorities for rare disease research in underrepresented European countries. European Journal of Public Health. 2026;36(4). doi:10.1093/eurpub/ckag103
BibTeX
@article{Lace2026,
author = {Lace, Baiba and Inashkina, Inna and Dan, Dorica and Weinman, Ariane and Adam, Pauline and Kvlividze, Oleg and Tumiene, Birute and Isidro, Anabela and Pereira, Carlos Almeida and Teixeira, Gonçalo and Crowley, Rachel K and ERDERA UC Stakeholder Panel, ERDERA UC Stakeholder Panel},
title = {Identifying barriers and policy priorities for rare disease research in underrepresented European countries},
journal = {European Journal of Public Health},
year = {2026},
volume = {36},
number = {4},
doi = {10.1093/eurpub/ckag103}
}
EUVIMED